IZI Medical Products, an interventional radiology medical device company, acquired soft tissue biopsy and breast localization needle assets from Cook Medical. This is IZI’s third add-on acquisition in the last 18 months.

The extra butter, cream and fats that go into Christmas cooking may raise people’s risk of elevated cholesterol by up to six times immediately following the holidays, suggesting diagnoses of hypercholesterolemia should wait until later in the year, according to a Danish study published in Atherosclerosis.

Unnecessary imaging is a serious problem in the United States. So what can be done about it? A new analysis published in the Journal of the American Medical Association explored that very question.

Overall cancer deaths in the United States have steadily declined by 27 percent over the past quarter century, according to a new review from the American Cancer Society (ACS).

Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia, Canada, is soon to be home to the first MRI scanner in an emergency department in the entire province.

More than 75 percent of healthcare executive leaders said their organization is increasing the pace of investment in big data and AI, with a majority citing fear of disruption by competitors, according to a survey by NewVantage Partners.

President Trump summoned top officials for a meeting at the White House on Jan. 8, Politico reported. The meeting comes as major drugmakers raised prices at the start of the year, prompting a Twitter response from the president.

The findings suggest the evaluation of molecular biomarkers for Alzheimer’s disease should be adjusted for race, as African American patients were found to have lower levels of tau—a key biomarker used to identify the disease, according to research published online Jan. 7 in JAMA Neurology.

Elevated levels of cardiac troponin signal an increased risk of cardiovascular events even when the cause of that elevation is unknown, suggests a study published in the Journal of the American College of Cardiology.

Lark’s clinically validated AI coaching programs provide new ways for 23andMe customers to take action on their genetic information